Michael R. Rosen – författare

New Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies.

This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase.

The elite panel of authors have explored fresh information on:

advances in antiarrhythmic pharmacologis therapy advances in monitoring, risk assessment, and noninvasive mapping advances in pacing therapy advances in implantable defibrillators advances in catheter and surgical ablation advances in antiarrhythmic biological therapy vision for the future of arrhythmia technologies web-based defibrillation monitoring.

New Arrhythmia Technologies presents a unique view of the latest in arrhythmia innovations through the eyes of the experts in the field.

Proceedings of the Second Rappaport Symposium, Haifa, Israel, March 13-16, 1988

Cardiac therapy has become ever more complex during the past quarter century. For example, 25 years ago, the therapy of cardiac failure was largely limited to digitalis, a very few diuretics, salt restriction, and general supportive measures. Antiarrhythmic therapy involved - in the main - quinidine, procainamide, and digitalis, and questions such as which arrhythmia to treat and how to measure drug efficacy had been addressed in elementary fashion only. Cardiac surgery was limited largely to congenital and valvular heart disease; the areas of cardiac pacemaker therapy, defibrillation and other forms of electrical diagnosis and therapy were rudimentary. The expansion of support of cardiovascular research by the National Institutes of Health as well as by institutional sources following World War II has led to major successes in clinical health care delivery and improved technology made available to clinical investigators. In reviewing progress over the past 25 years, we have been particularly impressed by one observation: this is the important interaction that has developed between studies of pathophysiology and the delivery of appropriate cardiac therapy.

New Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies.This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase.The elite panel of authors have explored fresh information on: advances in antiarrhythmic pharmacologis therapyadvances in monitoring, risk assessment, and noninvasive mappingadvances in pacing therapyadvances in implantable defibrillatorsadvances in catheter and surgical ablationadvances in antiarrhythmic biological therapyvision for the future of arrhythmia technologiesweb-based defibrillation monitoring.New Arrhythmia Technologies presents a unique view of the latest in arrhythmia innovations through the eyes of the experts in the field.

Proceedings of the Second Rappaport Symposium, Haifa, Israel, March 13-16, 1988

Cardiac therapy has become ever more complex during the past quarter century. For example, 25 years ago, the therapy of cardiac failure was largely limited to digitalis, a very few diuretics, salt restriction, and general supportive measures. Antiarrhythmic therapy involved - in the main - quinidine, procainamide, and digitalis, and questions such as which arrhythmia to treat and how to measure drug efficacy had been addressed in elementary fashion only. Cardiac surgery was limited largely to congenital and valvular heart disease; the areas of cardiac pacemaker therapy, defibrillation and other forms of electrical diagnosis and therapy were rudimentary. The expansion of support of cardiovascular research by the National Institutes of Health as well as by institutional sources following World War II has led to major successes in clinical health care delivery and improved technology made available to clinical investigators. In reviewing progress over the past 25 years, we have been particularly impressed by one observation: this is the important interaction that has developed between studies of pathophysiology and the delivery of appropriate cardiac therapy.

Cardiac therapy has become ever more complex during the past quarter century. For example, 25 years ago, the therapy of cardiac failure was largely limited to digitalis, a very few diuretics, salt restriction, and general supportive measures. Antiarrhythmic therapy involved - in the main - quinidine, procainamide, and digitalis, and questions such as which arrhythmia to treat and how to measure drug efficacy had been addressed in elementary fashion only. Cardiac surgery was limited largely to congenital and valvular heart disease; the areas of cardiac pacemaker therapy, defibrillation and other forms of electrical diagnosis and therapy were rudimentary. The expansion of support of cardiovascular research by the National Institutes of Health as well as by institutional sources following World War II has led to major successes in clinical health care delivery and improved technology made available to clinical investigators. In reviewing progress over the past 25 years, we have been particularly impressed by one observation: this is the important interaction that has developed between studies of pathophysiology and the delivery of appropriate cardiac therapy.

This book honors the career of Professor Elizabeth Gierlowski-Kordesch who was a pioneer and leader in the field of limnogeology since the 1980s. Her work was instrumental in guiding students and professionals in the field until her untimely death in 2016. This collection of chapters was written by her colleagues and students and recognize the important role that Professor Gierlowski-Kordesch had in advancing the field of limnogeology. The chapters show the breadth of her reach as these have been contributed from virtually every continent.This book will be a primary reference for scientists, professionals and graduate students who are interested in the latest advances in limnogeologic processes and basin descriptions in North and South America, Europe, Africa, and China.*Free supplementary material available online for chapters 3,11,12 and 13.Access by searching for the book on link.springer.com

This book honors the career of Professor Elizabeth Gierlowski-Kordesch who was a pioneer and leader in the field of limnogeology since the 1980s. Her work was instrumental in guiding students and professionals in the field until her untimely death in 2016. This collection of chapters was written by her colleagues and students and recognize the important role that Professor Gierlowski-Kordesch had in advancing the field of limnogeology. The chapters show the breadth of her reach as these have been contributed from virtually every continent.This book will be a primary reference for scientists, professionals and graduate students who are interested in the latest advances in limnogeologic processes and basin descriptions in North and South America, Europe, Africa, and China.*Free supplementary material available online for chapters 3,11,12 and 13.Access by searching for the book on link.springer.com

This book honors the career of Professor Elizabeth Gierlowski-Kordesch who was a pioneer and leader in the field of limnogeology since the 1980s. Her work was instrumental in guiding students and professionals in the field until her untimely death in 2016. This collection of chapters was written by her colleagues and students and recognize the important role that Professor Gierlowski-Kordesch had in advancing the field of limnogeology. The chapters show the breadth of her reach as these have been contributed from virtually every continent.This book will be a primary reference for scientists, professionals and graduate students who are interested in the latest advances in limnogeologic processes and basin descriptions in North and South America, Europe, Africa, and China.*Free supplementary material available online for chapters 3,11,12 and 13.Access by searching for the book on link.springer.com

The human footprint on the global environment now touches every corner of the world. This book explores the myriad ways that environmental archives can be used to study the distribution and long-term trajectories of chemical contaminants. The volume first focuses on reviews that examine the integrity of the historic record, including factors related to hydrology, post-depositional diffusion, and mixing processes. This is followed by a series of chapters dealing with the diverse archives and methodologies available for long-term studies of environmental pollution, such as the use of sediments, ice cores, sclerochronology, and museum specimens.

The human footprint on the global environment now touches every corner of the world. This book explores the myriad ways that environmental archives can be used to study the distribution and long-term trajectories of chemical contaminants. The volume first focuses on reviews that examine the integrity of the historic record, including factors related to hydrology, post-depositional diffusion, and mixing processes. This is followed by a series of chapters dealing with the diverse archives and methodologies available for long-term studies of environmental pollution, such as the use of sediments, ice cores, sclerochronology, and museum specimens.